Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Endokrynologia Polska is Scopus-indexed (Q3, CiteScore 2.9), WoS SCIE, DOAJ. Published by Via Medica.
Checked against the index lists dated .
ISSN 0423-104XVerify ISSN ↗2299-8306Verify ISSN ↗
Publisher: Via Medica
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 164 / 250 | 34th | Q3 |
| Endocrinology | 101 / 132 | 23rd | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present (also 1991–1993, 1961–1989), best quartile Q3, CiteScore 2.9.
Endokrynologia Polska is Q3 in Endocrinology, Diabetes and Metabolism (rank 164 of 250) and Q4 in Endocrinology (rank 101 of 132), by CiteScore 2025.
Endokrynologia Polska is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.9, which places it in quartile Q3 at the 34th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.501, quartile Q3, with an H-index of 41.
The publisher lists an article processing charge of about US$539 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Endokrynologia Polska is published by Via Medica. Its print ISSN is 0423-104X and its online ISSN is 2299-8306.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Endokrynologia Polska has an h-index of 39 and a 2-year mean of 1.4 citations per paper (OpenAlex). Its Scopus CiteScore is 2.9, quartile Q3. On 2-year citations it ranks #157 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Endokrynologia Polska published 93 papers in 2025; its busiest recent year was 2020 with 108. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from Poland (55.1%), China (25.5%) and Türkiye (12.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.